Ossium Health Advertises Stem Cell Therapy in San Francisco, California
About Ossium Health
Ossium Health is a therapeutics company based in San Francisco, CA, with offices in Indianapolis. The company advertises a deceased donor bone marrow banking platform and the development of stem cell therapies for blood and immune diseases. It also lists specific cell products for research use.
Ossium Health describes itself as a therapeutics company founded in 2016. Its mission is to improve human health, vitality, and longevity through bioengineering. The company operates a deceased donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood, immune, and inflammatory diseases. Leadership includes Co-Founder and CEO Kevin Caldwell and Co-Founder and Chief Science Officer Erik Woods.
The practice advertises partnerships with healthcare providers, life science companies, and organ procurement organizations. It has conducted Phase I studies with Columbia University Irving Medical Center regarding intestinal transplantation and immunosuppression minimization. The company also lists a partnership with the National Marrow Donor Program (NMDP)/Be The Match to increase bone marrow transplant accessibility.
Ossium Health advertises specific cell products for research use, including GMP Selected CD34+ Cells from HPC and Marrow, and RUO Cryopreserved Mesenchymal Stem Cells (MSCs). These products are derived from the vertebral bodies of organ donors. The company maintains an Indianapolis office in addition to its San Francisco location.
Common questions about Ossium Health
Where is Ossium Health located?
Ossium Health has offices in San Francisco, CA, and Indianapolis.
What is Ossium Health's mission?
The company's mission is to improve the health, vitality, and longevity of human beings through bioengineering.
What products does Ossium Health advertise?
Ossium Health advertises GMP Selected CD34+ Cells from HPC and Marrow, and RUO Cryopreserved MSCs.